Regorafenib in Relapsed Glioblastoma

NCT02926222 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

119

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma Multiforme

Interventions

DRUG: Regorafenib
DRUG: Lomustine

Sponsor

Istituto Oncologico Veneto IRCCS

Collaborators

[object Object]